Literature DB >> 21533706

What future for treatment of chronic migraine with medication overuse?

Licia Grazzi1, G Bussone.   

Abstract

Chronic headaches have increasingly become a focus within the field of head pain. Most of the patients with frequent headache eventually overuse their medications, and if it happens [the percentage is approximately 4%], the diagnosis of chronic migraine with medication-overuse headache is clinically important, because patients rarely respond to preventive medications while overusing acute medications. This kind of headache is recognized as a biobehavioral disorder, a complex condition wherein emotion and pain are intermingled. Properly treating medication overuse with adequate strategies by different and specific steps are essential components for helping these patients to improve and for preventing relapses. The clinical experience performed at our Headache Unit, the necessity of withdrawal, different treatment schedules, and different treatment strategies of our center were discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533706     DOI: 10.1007/s10072-011-0553-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  23 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

Review 2.  The primary headaches as a reflection of genetic darwinian adaptive behavioral responses.

Authors:  Pasquale Montagna; Giulia Pierangeli; Pietro Cortelli
Journal:  Headache       Date:  2009-12-21       Impact factor: 5.887

3.  Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.

Authors:  Chelsea A Meskunas; Stewart J Tepper; Alan M Rapoport; Fred D Sheftell; Marcelo E Bigal
Journal:  Headache       Date:  2006-05       Impact factor: 5.887

4.  The impact of intensive patient education on clinical outcome in a clinic-based migraine population.

Authors:  John Farr Rothrock; Victoria A Parada; Cheryl Sims; Kristin Key; Naomi S Walters; Richard M Zweifler
Journal:  Headache       Date:  2006-05       Impact factor: 5.887

Review 5.  Modifiable risk factors for migraine progression.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

Review 6.  Medication overuse headache: biobehavioral issues and solutions.

Authors:  Alvin E Lake
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

7.  Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years.

Authors:  Licia Grazzi; Frank Andrasik; Domenico D'Amico; Massimo Leone; Susanna Usai; Steven J Kass; Gennaro Bussone
Journal:  Headache       Date:  2002-06       Impact factor: 5.887

Review 8.  Medication-overuse headache: a worldwide problem.

Authors:  Hans-Christoph Diener; Volker Limmroth
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

9.  Biofeedback treatment for headache disorders: a comprehensive efficacy review.

Authors:  Yvonne Nestoriuc; Alexandra Martin; Winfried Rief; Frank Andrasik
Journal:  Appl Psychophysiol Biofeedback       Date:  2008-08-26

10.  Treatment of chronic migraine with medication overuse: is drug withdrawal crucial?

Authors:  Licia Grazzi; Frank Andrasik; Susanna Usai; Gennaro Bussone
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

View more
  2 in total

1.  A 14-month study of change in disability and mood state in patients with chronic migraine associated to medication overuse.

Authors:  A Raggi; M Leonardi; A M Giovannetti; S Schiavolin; G Bussone; L Grazzi; S Usai; M Curone; P Di Fiore; D D'Amico
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

Review 2.  Medication-overuse headache: a widely recognized entity amidst ongoing debate.

Authors:  Nicolas Vandenbussche; Domenico Laterza; Marco Lisicki; Joseph Lloyd; Chiara Lupi; Hannes Tischler; Kati Toom; Fenne Vandervorst; Simone Quintana; Koen Paemeleire; Zaza Katsarava
Journal:  J Headache Pain       Date:  2018-07-13       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.